Friday, May 20, 2016

China Drug Deal Will Slash Prices of Top Treatments

China said it would cut the prices of three top-selling drugs, including treatments from AstraZeneca and GlaxoSmithKline, by between as much as 67% as part of efforts to make innovative medicines more affordable.

from WSJ.com: US Business http://ift.tt/1rYSvvq
via IFTTT

No comments:

Post a Comment